Ipamorelin is a pentapeptide (AIB-His-D-2-Nal-D-Phe-Lys-NH2 which shows a high ability and efficiency in the release of growth hormone.
Ipamorelin injectable induces the secretion of growth hormone and mimics ghrelin in the body. The unique properties of Ipamorelin include more stimulation of growth hormone (GH) production than other GHRPs, as well as selective GH production. Ipamorelin is the second generation of GHRP (growth hormone-releasing peptide). Unlike its predecessors GHRP-2 and GHRP-6, ipamorelin does not cause the side effects of intense hunger or increased levels of prolactin and cortisol.
The significant release of growth hormone itself is associated with both the suppression of somatostatin and the stimulation of the release of growth hormone GH from the anterior pituitary gland, as is the case with GHRP-6. When using Ipamorelin with growth hormone stimulants such as GRF 1-29 and CJC-1295, these peptides multiply the effect of each other, which gives an even greater release of growth hormone. Please consult your doctor about Ipamorelin injectable dosage.
Other Names: Ipamorelin, 170851-70-4, C38H49N9O5, CHEMBL58547, SCHEMBL183305, SCHEMBL8169698, MolPort-039-139-953, 5020AF, ZINC29562299, AKOS030573449, DB12370, NCGC00167295-01, FT-0696037, L-Lysinamide,2-methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl-
Molecular Formula: C38H49N9O5
Molar Mass: 711.85296
CAS Number: 170851-70-4
PubChem: CID 20754357
Total Amount of the Active Ingredient: 2 mg (1 vial)
Top Color: Pink
Shelf Life: 36 months
Minimum Order: 1 vial
Peptides are stable at room temperature and can be kept in their initial packaging for several days to weeks. Otherwise, peptides can be stored at 4 °C or colder. To preserve product quality, keep away from intense light.
Peptides shouldn’t be shaken before or after reconstitution, must be refrigerated, and always handled with care.
Ipamorelin 2 mg should be reconstituted with bacteriostatic water (BAC).
All of our products are lab tested and the results are periodically published on the website.
What is Ipamorelin?
Ipamorelin is a growth hormone secretagogue because it is a peptide-specific agonist of the ghrelin or growth hormone secretagogue receptor. It works by attaching to either growth hormone secretion or ghrelin receptors, causing the body to create more growth hormone as a result of the biological response.
Like CJC 1295, ipamorelin has been proven to enhance plasma growth hormone levels and encourage weight gain in its users. Ipamorelin has no effect on prolactin, the hormone that instructs a woman’s body to begin producing milk. Follicle stimulation hormone, luteinizing hormone, and thyroid stimulating hormone are also unaffected.
Benefits and Uses
If you’re looking for a way to slow down the aging process and replace what’s been lost due to natural aging, Ipamorelin has a lot to offer, including:
- Increased lean muscle mass as a result of new muscle cell proliferation
- Workouts and recovery have improved.
- Body fat has decreased.
- Increased stamina, strength, and energy
- Sleep that is more peaceful and deeper
- Pain in the joints and muscles is lessened.
- Increased desire for sex
- Improved skin tone and texture leading to fewer wrinkles
- Mental clarity has improved
- Wound healing speeded up
- An immune system that is stronger
- Hair that is thicker and fuller
- Bone density and strength have improved.
- Injury healing time is reduced.
- It improves the health of your heart and circulatory system.
- Aging is being slowed.
Additional Information on Ipamorelin
Ipamorelin is an anti-aging peptide with a short half-life. It gets to work swiftly in the body, but the amount of action falls off quickly as well. Ipamorelin has a half-life of roughly 2 hours, which means it loses 75 percent of its efficiency in 4 hours. This rate differs from that of other anti-aging peptides, making it a good candidate for combination therapy.
CJC-1295, for example, can take up to 4 hours to begin working but can last up to a week. The growth hormone-releasing actions are started by ipamorelin, and as its efficacy wears off, the CJC-1295 takes over. Ipamorelin is commonly compounded in a 1:1 ratio and given as a blended subcutaneous injection with a daily dosage of 300 mcg (microgram).